banner
 
bar

program

slides
bar
 
 

Optimizing Comprehensive Care and Referral Strategies for the Optometrist

WebCAST

CME Test
After Viewing Program, Please Click Here to Access the CME Test
Viewer Survey
How long did you spend on this program?

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Program Medium

Internet-based program

Estimated Time to Complete Educational Activity

2.5 hours

Course Overview

In this web-based program, physicians and optometrists will learn how recent developments in retinal screening have helped to advance the management of diabetic macular edema and age related macular degeneration.

Release Date

March 16, 2017

Expiration Date

March 16, 2019

Method of Physician Participation Utilized in Learning Process

There are no fees for participating and receiving CME credit for this activity. During the period March 17,2017 through March 17, 2019 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 6 segments totaling 2.5 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.

Registration

Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support

Supported by an educational grant from Regeneron Pharmaceuticals

Accreditation Statement

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School and CMEducation Resources, LLC. University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Massachusetts Medical School designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Program Faculty and Disclosure

PAUL M. KARPECKI, OD, FAAO
Clinical Director
Kentucky Eye Institute
Retina Associates of Kentucky
Lexington KY

Consultant: Aerie Pharmaceuticals, Akorn, Alcon, Allergan, AMO, Anthem, Avellino Labs, Bausch + Lomb, Beaver Visitech, BioTissue, Cambium Pharmaceuticals, Calhoun Vision, Candor Pharmaceuticals, Essilor, eyeBrain, Eyemaginations/Rendia, Eyes4Lives, Focus Labs, iCare USA, Imprimis, Katena, Konan Medical, Lubris Inc, Maculogix, Ocular Therapeutix, Oculus, OcuSoft, Paragon Biotek, PECAA, Perrigo, Quark Pharmaceuticals, Regeneron, Reichert/Ametek, Retina Sciences, RySurg, Science Based Health, Shire Pharmaceuticals, Sun Pharmaceuticals, TearFilm Innovation, TearScience, TelScreen, Topcon, Visiometrics, Vision Care Inc, Vmax
Research Grant: Shire Pharmaceuticals
Speaker’s Bureau: Shire Pharmaceuticals
Ownership Interest: Bruder Healthcare, Eye Therapies, Optometric Medical Solutions, TearLab



RISHI P. SINGH, MD
Staff Physician
Cleveland Clinic Cole Eye Institute
Assistant Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH

Consultant: Genentech, Regeneron, Shire, Zeiss, Optos
Grant/Research Support: Regeneron, Alcon, Genentech, Apellis




MARK T. DUNBAR, OD, FAAO
Director of Optometry
University of Miami, Bascom Palmer Eye Institute
Miami, FL

Speaker’s Bureau: Regeneron, Genentech


VIVIAN A. FONSECA, MD, FRCP
Professor of Medicine and Pharmacology
Tulis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
President, Science and Medicine (2012)
American Diabetes Association (ADA)

Consulting and Lectures: Takeda, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Pamlabs, Astra Zeneca, Abbott, Amgen, Boehringer Ingelheim, Janssen
Research Support (to Tulane): Grants from Novo-Nordisk, Asahi, Eli Lilly, Abbott, Endo Barrier, Gilead Sciences

Program Managers and Web Editor Disclosure

Program Manager Gideon Bosker, MD has nothing to disclose. Program reviewer Denise Leary has nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Detail the practical, case-based and guideline-consistent approaches for the optometry specialist when screening a broad range of patients at risk for age-related macular degeneration (AMD) and diabetic macular edema (DME);
  • Apply optometry-focused screening methodologies—among them, in-office/in-clinic screening devices, evolving technologies for evaluation of retinal disease, dilated eye exams, telemedicine technology, optometrist-based screening and referral etc.—to optimize detection and referral to retina specialists for definitive treatment and prevention of progressive eye pathology and blindness in the setting of optometry and diabetes practice;
  • Understand the disease burden, epidemiology, consequences, identification, disease state classification, and multiple clinical manifestations and symptoms of DME, AMD, and related conditions as they present to the front lines of optometry practice;
  • Apply at the front lines of optometry practice national association guidelines for systematic screening and eye findings-directed referral to retina specialists;
  • Recognize which patient populations should be screened in the optometry and diabetes specialist setting and how often, and what specific technologies should be used to optimize detection of DME and AMD.

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

  • We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
  • For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
  • We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
  • If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
  • You should check this privacy policy periodically to see whether we have made any changes.

Disclaimer

Copyright © 2017 by CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

bar

program

slides
bar

I have read this CME information statement and wish to participate in this CME activity.

Copyright © CMEducation Resources, LLC

 
6

 

Key Program Topics Include:

Age- Related Macular Generation
aHUS
AMD
Anti-VEGF
Atypical hemolytic uremic syndrome
CFH
Cicatrization
Color Fundus

Compliment Factor H
Diabetes
Diabetic Edema
Diabetic Retinopathy
dry AMD
FAF
IRMA
Ischemia
Membraneoproliferative glomerulonephritis type II

 

MGNII
Microaneurysm
Mild to Moderate Nonproliferative
NPDR
Optometry
optometrist
Paroxymal nocturnal hematuria
photoreceptors

PNH
Retina
Retinal screening
RPE
Vascular Endothelial Growth Factor
Vascular permeability
VEGF
VEGF-A
vitreous
wet AMD